A study for a 42 year old woman who takes Flonase, Benzonatate, Allegra Allergy - from FDA reports

Summary

632 females aged 42 (±5) who take the same drugs are studied. This is a personalized study for a 42 year old female patient who has Allergic Sinusitis, Adenoviral Upper Respiratory Infection, Allergy. The study is created by eHealthMe based on reports from FDA.



How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

What are the drugs?

What are the conditions?

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

632 females aged 42 (±5) who take Flonase, Benzonatate, Allegra Allergy are studied.


Number of reports submitted per year:

Flonase, Benzonatate, Allegra Allergy for a 42-year old woman.

Information of the patient in this study:

  • Age: 42
  • Gender: female
  • Conditions: Allergic Sinusitis, Adenoviral Upper Respiratory Infection, Allergy
  • Drugs taken:
    • Flonase (fluticasone propionate)
    • Benzonatate (benzonatate)
    • Allegra Allergy (fexofenadine hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Drug ineffective
  2. Pharyngeal erythema (pharyngeal redness)
  3. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death)
  4. Cataract (clouding of the lens inside the eye)
  5. Ill-defined disorder
  6. Oedema peripheral (superficial swelling)
  7. High blood pressure
  8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Gait disturbance
1 - 6 months:
  1. Weight increased
  2. Memory loss
  3. Sedation
  4. Hypertension aggravated (high blood pressure-aggravated)
  5. Constipation
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Asthma aggravated
  8. Insomnia (sleeplessness)
  9. Diabetes mellitus aggravated (serious diabetes)
  10. Pulmonary embolism (blockage of the main artery of the lung)
6 - 12 months:
  1. Hypersensitivity
  2. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  3. Blood alkaline phosphatase increased
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Pre-existing condition improved
  6. Jaundice - yellow skin (a yellowish pigmentation of the skin)
  7. Vulvovaginal mycotic infection (vulvovaginal fungal infection)
  8. Anaemia (lack of blood)
  9. Therapeutic response unexpected
  10. Monocyte count increased
1 - 2 years:
  1. Stress and anxiety
  2. Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Acute kidney failure
  4. Chronic kidney disease
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Breast cancer
  7. Depression
  8. Heart attack
  9. Pain in extremity
  10. Bipolar disorder (mood disorder)
2 - 5 years:
  1. Eye discharge
  2. Vision blurred
  3. Fungal infection
  4. Cataract (clouding of the lens inside the eye)
  5. Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Dry eye syndrome
  7. Pain in extremity
  8. Pain
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Antiphospholipid syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss)
5 - 10 years:
  1. Staphylococcal infection (an infection with staphylococcus bacteria)
  2. Chronic kidney disease
  3. Eye infection
  4. Pre-existing condition improved
  5. Rhinorrhea (watery mucus discharge from the nose)
  6. Nasal ulcer (ulcer of nose)
  7. Connective tissue disorder (any disease that has the connective tissues of the body)
  8. Adrenal insufficiency (condition in which the adrenal glands do not produce adequate amounts of steroids)
10+ years:
  1. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  2. Therapeutic response unexpected
  3. Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
  4. Rhinorrhea (watery mucus discharge from the nose)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Pre-existing condition improved
  7. Irritable bowel syndrome
not specified:
  1. Chest pain
  2. Nausea (feeling of having an urge to vomit)
  3. Headache (pain in head)
  4. Pain
  5. Breathing difficulty
  6. Fatigue (feeling of tiredness)
  7. Stress and anxiety
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Weakness
  10. Rashes (redness)

Top conditions involved for these people *:

  1. Asthma : 91 people, 14.40%
  2. Hypersensitivity : 58 people, 9.18%
  3. Pain : 47 people, 7.44%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 46 people, 7.28%
  5. Depression : 40 people, 6.33%
  6. Birth Control : 37 people, 5.85%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 37 people, 5.85%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 28 people, 4.43%
  9. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 28 people, 4.43%
  10. High Blood Pressure : 27 people, 4.27%

Top co-used drugs for these people *:

  1. Singulair (124 people, 19.62%)
  2. Albuterol (83 people, 13.13%)
  3. Zyrtec (68 people, 10.76%)
  4. Nexium (54 people, 8.54%)
  5. Xyrem (51 people, 8.07%)
  6. Protonix (48 people, 7.59%)
  7. Synthroid (45 people, 7.12%)
  8. Yasmin (44 people, 6.96%)
  9. Prilosec (43 people, 6.80%)
  10. Prednisone (43 people, 6.80%)

* Some reports may have incomplete information.

What is next?

You are not alone:




Related studies:



FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.